Journal of Applied Physiology, Vol 68, Issue 2 735-747, Copyright © 1990 by American Physiological Society

ARTICLES

Comparison of the hemodynamic effects of nitric oxide and endothelium-dependent vasodilators in intact lungs

S. L. Archer, K. Rist, D. P. Nelson, E. G. DeMaster, N. Cowan and E. K. Weir
Department of Medicine, Veterans Administration Medical Center, Minneapolis, Minnesota 55407.

The effects of endothelium-dependent vasodilation on pulmonary vascular hemodynamics were evaluated in a variety of in vivo and in vitro models to determine 1) the comparability of the hemodynamic effects of acetylcholine (ACh), bradykinin (BK), nitric oxide (NO), and 8-bromo-guanosine 3',5'-cyclic monophosphate (cGMP), 2) whether methylene blue is a useful inhibitor of endothelium-dependent relaxing factor (EDRF) activity in vivo, and 3) the effect of monocrotaline-induced pulmonary hypertension on the responsiveness of the pulmonary vasculature to ACh. In isolated rat lungs, which were preconstricted with hypoxia, ACh, BK, NO, and 8-bromo-cGMP caused pulmonary vasodilation, which was not inhibited by maximum tolerable doses of methylene blue. Methylene blue did not inhibit EDRF activity in any model, despite causing increased pulmonary vascular tone and responsiveness to various constrictor agents. There were significant differences in the hemodynamic characteristics of ACh, BK, and NO. In the isolated lung, BK and NO caused transient decreases of hypoxic vasoconstriction, whereas ACh caused more prolonged vasodilation. Pretreatment of these lungs with NO did not significantly inhibit ACh-induced vasodilation but caused BK to produce vasoconstriction. Tachyphylaxis, which was agonist specific, developed with repeated administration of ACh or BK but not NO. Tachyphylaxis probably resulted from inhibition of the endothelium-dependent vasodilation pathway proximal to NO synthesis, because it could be overcome by exogenous NO. Pretreatment with 8-bromo-cGMP decreased hypoxic pulmonary vasoconstriction and, even when the hypoxic pressor response had largely recovered, subsequent doses of ACh and NO failed to cause vasodilation, although BK produced vasoconstriction. These findings are compatible with the existence of feedback inhibition of the endothelium-dependent relaxation by elevation of cGMP levels. Responsiveness to ACh was retained in lungs with severe monocrotaline-induced pulmonary hypertension. Many of these findings would not have been predicted based on in vitro studies and illustrate the importance for expanding studies of EDRF to in vivo and ex vivo models.

This article has been cited by other articles:

				P. J. Bernal, K. Leelavanichkul, E. Bauer, R. Cao, A. Wilson, K. J. Wasserloos, S. C. Watkins, B. R. Pitt, and C. M. St. Croix Nitric Oxide-Mediated Zinc Release Contributes to Hypoxic Regulation of Pulmonary Vascular Tone Circ. Res., June 20, 2008; 102(12): 1575 - 1583. [Abstract] [Full Text] [PDF]

				J. S. Naik and B. R. Walker Homogeneous segmental profile of carbon monoxide-mediated pulmonary vasodilation in rats Am J Physiol Lung Cell Mol Physiol, December 1, 2001; 281(6): L1436 - L1443. [Abstract] [Full Text] [PDF]

				N. Weissmann, R. Voswinckel, A. Tadic, T. Hardebusch, H. A. Ghofrani, R. T. Schermuly, W. Seeger, and F. Grimminger Nitric Oxide (NO)-Dependent but Not NO-Independent Guanylate Cyclase Activation Attenuates Hypoxic Vasoconstriction in Rabbit Lungs Am. J. Respir. Cell Mol. Biol., August 1, 2000; 23(2): 222 - 227. [Abstract] [Full Text]

				S. Prie, D. J. Stewart, and J. Dupuis EndothelinA Receptor Blockade Improves Nitric Oxide–Mediated Vasodilation in Monocrotaline-Induced Pulmonary Hypertension Circulation, June 2, 1998; 97(21): 2169 - 2174. [Abstract] [Full Text] [PDF]

				M. Manohar and T. E. Goetz L-NAME does not affect exercise-induced pulmonary hypertension in Thoroughbred horses J Appl Physiol, June 1, 1998; 84(6): 1902 - 1908. [Abstract] [Full Text] [PDF]

				W. Steudel, F. Ichinose, P. L. Huang, W. E. Hurford, R. C. Jones, J. A. Bevan, M. C. Fishman, and W. M. Zapol Pulmonary Vasoconstriction and Hypertension in Mice With Targeted Disruption of the Endothelial Nitric Oxide Synthase (NOS 3) Gene Circ. Res., July 19, 1997; 81(1): 34 - 41. [Abstract] [Full Text]

				N. Finer Inhaled Nitric Oxide and Hypoxic Respiratory Failure in Infants With Congenital Diaphragmatic Hernia Pediatrics, June 1, 1997; 99(6): 838 - 845. [Abstract] [Full Text] [PDF]

				The Neonatal Inhaled Nitric Oxide Study Group Inhaled Nitric Oxide in Full-Term and Nearly Full-Term Infants with Hypoxic Respiratory Failure N. Engl. J. Med., February 27, 1997; 336(9): 597 - 604. [Abstract] [Full Text] [PDF]

				S. L. Archer, J. M.C. Huang, H. L. Reeve, V. Hampl, S. Tolarova, E. Michelakis, and E. K. Weir Differential Distribution of Electrophysiologically Distinct Myocytes in Conduit and Resistance Arteries Determines Their Response to Nitric Oxide and Hypoxia Circ. Res., March 1, 1996; 78(3): 431 - 442. [Abstract] [Full Text]

				C. J. Cooper, M. J. Landzberg, T. J. Anderson, F. Charbonneau, M. A. Creager, P. Ganz, and A. P. Selwyn Role of Nitric Oxide in the Local Regulation of Pulmonary Vascular Resistance in Humans Circulation, January 15, 1996; 93(2): 266 - 271. [Abstract] [Full Text]